Fit for Duty: Lessons Learned from Outpatient and Homebound Hematopoietic Cell Transplantation to Prepare Family Caregivers for Home-Based CareAllison J. Applebaum, Hermioni L. Amonoo, C. Pozo-Kaderman et al.|Transplantation and Cellular Therapy|2022Cited by 27
Worsening Financial Toxicity Among Patients Receiving Chimeric Antigen Receptor t-Cell (CAR-T) Therapy: A Mixed Methods Longitudinal StudyRachel Cusatis, Surbhi Sidana, Irena Tan et al.|Blood|2021Cited by 19
Patient-reported outcomes and neurotoxicity markers in patients treated with bispecific LV20.19 CAR T cell therapyJennifer M. Knight, Nirav N. Shah, Anikó Szabó et al.|Communications Medicine|2022Cited by 16
Assessing Quality of Life and Symptoms in Transplantation and CAR-T Recipients: Expert Panel Recommendations from the Survivorship Special Interest Group of ASTCTRahul Banerjee, Betty K. Hamilton, Hermioni L. Amonoo et al.|Transplantation and Cellular Therapy|2025Cited by 7
The health risk of social disadvantage is transplantable into a new hostLucie M. Turcotte, Jennifer M. Knight|Proceedings of the National Academy of Sciences|2024Cited by 4